Business

Danone Forecasts Steady Sales Growth, Limited Hit From Infant-Formula Recalls

Published

on

Danone BN -0.70%decrease; red down pointing triangle projected steady sales growth for the year ahead, with a muted impact from infant-formula recalls, as the French food maker sought to reassure investors that the hit wouldn’t linger for long.

The company behind Aptamil baby milk has been one of the companies affected by a tainted ingredient in its infant formula. Over the past few months, food companies including Danone and Nestle issued warnings or pulled infant nutrition labels off the shelf in more than 60 countries. Danone’s stock has fallen this year amid the recalls.

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version